Gliatilin, 600 mg/7 ml 7 ml 10 pcs

Attention and Memory Disorder, Stroke Consequences, Headache, Alzheimer’s Disease, Mental Disorders, Acquired Dementia, Aggressiveness and Conflict

Indications

Acute period of traumatic brain injury with predominantly brain stem level of damage, chronic cerebrovascular insufficiency (dyscirculatory encephalopathy);

Pharmacological effect

Cholinomimetic.

Special instructions

If nausea occurs, the dose should be reduced.

Active ingredient

Choline alphoscerate

Composition

One 7 ml bottle contains:

Contraindications

Pregnancy, lactation, hypersensitivity to choline alfoscerate.

Side Effects

Possible nausea.

Recommendations for use

Orally: 400 mg 3 times a day, course of treatment is 3-6 months. IM or IV: 1 g/day.

Manufacturer

Mifarm S.p.A., Italy